Iovance Biotherapeutics (IOVA) Net Margin (2023 - 2026)
Iovance Biotherapeutics' Net Margin came in at -47.64% for Q2 2026, up 138.60 percentage points from -186.25% a year earlier and up 63.02 percentage points from the prior quarter.
Powered by 
Analysis
Iovance Biotherapeutics (IOVA) Net Margin (2023 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Iovance Biotherapeutics reported Net Margin of -89.09%, up 72.35 percentage points year-over-year; for FY2025, it was -148.39%, up 78.45 percentage points from FY2024.
- Going back by year, Net Margin was -226.84% in FY2024 (+37118.58 pp) and -37345.42% in FY2023.
- The Q2 2026 figure represents the highest quarterly Net Margin in data going back to Q2 2023.
- Year-over-year, Net Margin has increased for nine consecutive quarters, with an average year-over-year change of +8017.18 percentage points over the last eight quarters.
- The year-over-year gain in Net Margin has ranged between 7.39 percentage points (Q3 2025) and 44447.50 percentage points (Q2 2024) over the last five years.
- Business Quant data shows IOVA's Net Margin at -110.66% (Q1 2026), -82.86% (Q4 2025) and -135.28% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | Iovance Biotherapeutics | 4.98 Bn | 3.77 Bn | 55.72 Mn | -47.64% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -47.64% |
| Mar 31, 2026 | -110.66% |
| Dec 31, 2025 | -82.86% |
| Sep 30, 2025 | -135.28% |
| Jun 30, 2025 | -186.25% |
| Mar 31, 2025 | -235.51% |
| Dec 31, 2024 | -106.60% |
| Sep 30, 2024 | -142.67% |
| Jun 30, 2024 | -312.16% |
| Mar 31, 2024 | -15,800.84% |
| Dec 31, 2023 | -24,145.02% |
| Sep 30, 2023 | -24,255.86% |
| Jun 30, 2023 | -44,759.66% |
API Access
Iovance Biotherapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=IOVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "IOVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=IOVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();